UTILIZATION MANAGEMENT

Utility of Post Op Lab Testing Questioned for Some Gynecologic Patients

Routine postoperative laboratory testing may be unnecessary in some gynecological patients, according to two abstracts presented at the Society of Gynecologic Oncology’s (SGO’s) Annual Meeting on … [Read more...]

TESTING STRATEGY

Low Histopathologic Agreement for DCIS, Atypia Breast Cancer

Pathologists disagree with one another’s interpretations about 8 percent of the time when diagnosing a single breast biopsy slide, according to a study published March 22 in the Annals of Internal … [Read more...]

TESTING STRATEGY

Molecular Profiling of Lung Cancer Tumors Feasible on National Scale

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening … [Read more...]

TESTING STRATEGY

Viewpoints Debate Merits of Universal Tumor Sequencing

By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies There is universal recognition that genomic information has forever changed oncology care and is increasingly driving treatment … [Read more...]

TESTING STRATEGIES

PSA Screening Cost Effective With ‘Smarter’ Approach

A combination of conservative screening and selective treatment strategies can make screening for prostate cancer cost effective, according to an economic analysis published March 24 in JAMA Oncology. … [Read more...]

TESTING STRATEGY

Acute HIV Screening With Combo Assay Ups Diagnostic Yield

Use of an HIV antigen/antibody (Ag/Ab) combination assay increases the diagnostic yield by more than 10 percent compared with rapid HIV testing in a high-prevalence population, while pooled RNA … [Read more...]


(-00000g2)